GleamWall
中文EN

SXTP 60 DEGREES PHARMACEUTICALS, INC.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1946563 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-2.8%
TTM net income YoY-4.7%
TTM EPS YoY95.7%
Revenue 3-yr CAGR115.4%
Net income 3-yr CAGR—

Margins

Gross margin24.1%
Operating margin-971.9%
Net margin-921.0%
FCF margin-906.9%
EBITDA margin-964.6%

Returns

ROE-316.7%
ROA-170.7%
ROIC (approx.)-1,197.4%
Asset turnover0.19x

Leverage & solvency

Liabilities / assets75.6%
Debt / equity0.18x
Current ratio1.17x
Interest coverage-1,207.18x

Cash quality & payout

Operating cash flow / net income0.97x
Accruals ratio-4.8%
Payout ratio—
Capex / revenue12.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$1.01M$607,574
Cost of revenue$781,695$384,765
Gross profit$223,776$222,809
R&D expense$2.11M$4.99M
SG&A expense$6.28M$5.03M
Operating income-$7.76M-$9.72M
Interest expense$7,805$7,912
Pretax income-$7.37M-$7.96M
Income tax$0$0
Net income-$7.37M-$7.95M
EBITDA-$7.72M-$9.70M
EPS (basic)-11.73-74.17
EPS (diluted)-11.73-74.17
Weighted avg. shares (diluted)670,211113,665
Balance sheet
Cash & equivalents$1.51M$1.66M
Short-term investments$1.24M$1.73M
Receivables$509,644$486,748
Inventory$656,924$442,764
Current assets$4.90M$5.39M
PP&E, net$246,365$149,808
Intangibles$224,361$157,084
Total assets$5.37M$5.76M
Current liabilities$1.85M$1.66M
Short-term debt$11,517$8,772
Long-term debt$144,003$147,119
Total debt$155,520$155,891
Total liabilities$1.99M$1.80M
Shareholders' equity$3.46M$4.04M
Net debt-$1.35M-$1.50M
Shares outstanding1.16M141,749
Cash flow statement
Operating cash flow-$6.85M-$5.65M
Capital expenditure$139,881$103,773
Free cash flow-$6.99M-$5.75M
Investing cash flow$254,916-$1.89M
Financing cash flow$6.44M$7.05M
Depreciation & amortization$43,324$11,726
Stock-based compensation$456,344$3.61M

Free plan shows the latest 2 periods; Pro shows all 4 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.